Immunity and acquired alterations in cognition and emotion: Lessons from SLE

被引:36
作者
Diamond, B [1 ]
Kowal, C
Huerta, PT
Aranow, C
Mackay, M
DeGiorgio, LA
Lee, J
Triantaylopoulou, A
Cohen-Solal, J
Volpe, BT
机构
[1] Columbia Univ, Ctr Med, Dept Med, New York, NY 10027 USA
[2] Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, White Plains, NY 10605 USA
[3] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA
来源
ADVANCES IN IMMUNOLOGY, VOL 89 | 2006年 / 89卷
关键词
D O I
10.1016/S0065-2776(05)89007-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Classic immunologic teaching describes the brain as an immunologically privileged site. Studies of neuroimmunology have focused for many years almost exclusively on multiple sclerosis, a disease in which inflammatory cells actually infiltrate brain tissue, and the rodent model of this disease, experimental allergic encephalitis. Over the past decade, however increasingly, brain-reactive antibodies have been demonstrated in the serum of patients with numerous neurological diseases. The contribution these antibodies make to neuronal dysfunction has, in general, not been determined. Here, we describe recent studies showing that serum antibodies to the N-methyl D-asparate receptor occur frequently in patients with systemic lupus erythematosus and can cause alterations in cognition and behavior following a breach in the blood-brain barrier.
引用
收藏
页码:289 / 320
页数:32
相关论文
共 175 条
  • [1] Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions
    Aarts, M
    Liu, YT
    Liu, LD
    Besshoh, S
    Arundine, M
    Gurd, JW
    Wang, YT
    Salter, MW
    Tymianski, M
    [J]. SCIENCE, 2002, 298 (5594) : 846 - 850
  • [2] Molecular mechanisms underlying specificity of excitotoxic signaling in neurons
    Aarts, MM
    Tymianski, M
    [J]. CURRENT MOLECULAR MEDICINE, 2004, 4 (02) : 137 - 147
  • [3] The blood-brain barrier in systemic lupus erythematosus
    Abbott, NJ
    Mendonça, LLF
    Dolman, DEM
    [J]. LUPUS, 2003, 12 (12) : 908 - 915
  • [4] Action of glucocorticoids on survival of nerve cells:: Promoting neurodegeneration or neuroprotection?
    Abrahám, IM
    Harkany, T
    Horvath, KM
    Luiten, PGM
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2001, 13 (09) : 749 - 760
  • [5] Neuropsychiatric systemic lupus erythematosus - Correlation of brain MR imaging, CT, and SPECT
    Abreu, MR
    Jakosky, A
    Folgerini, M
    Brenol, JCT
    Xavier, RM
    Kapczinsky, F
    [J]. CLINICAL IMAGING, 2005, 29 (03) : 215 - 221
  • [6] The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus
    Ainiala, H
    Loukkola, J
    Peltola, J
    Korpela, M
    Hietaharju, A
    [J]. NEUROLOGY, 2001, 57 (03) : 496 - 500
  • [7] Systemic lupus erythematosus in three ethnic groups:: III A comparison of characteristics early in the natural history of the LUMINA cohort
    Alarcón, GS
    Friedman, AW
    Straaton, KV
    Moulds, JM
    Lisse, J
    Bastian, HM
    McGwin, G
    Bartolucci, AA
    Roseman, JM
    Reveille, JD
    [J]. LUPUS, 1999, 8 (03) : 197 - 209
  • [8] Tumor-specific killer cells in paraneoplastic cerebellar degeneration
    Albert, ML
    Darnell, JC
    Bender, A
    Francisco, LM
    Bhardwaj, N
    Darnell, RB
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1321 - 1324
  • [9] GLUCOCORTICOID ENDANGERMENT OF HIPPOCAMPAL-NEURONS IS NMDA-RECEPTOR DEPENDENT
    ARMANINI, MP
    HUTCHINS, C
    STEIN, BA
    SAPOLSKY, RM
    [J]. BRAIN RESEARCH, 1990, 532 (1-2) : 7 - 12
  • [10] STUDIES OF THE ROLE OF THE N-METHYL-D-ASPARTATE (NMDA) RECEPTOR IN THE HYPOTHALAMIC CONTROL OF PROLACTIN SECRETION
    ARSLAN, M
    POHL, CR
    SMITH, MS
    PLANT, TM
    [J]. LIFE SCIENCES, 1992, 50 (04) : 295 - 300